CeQur's insulin delivery device is a simple and discrete new insulin delivery tool for people who could benefit
from intensive insulin therapy but want flexibility and freedom from multiple daily injections.
-
CeQur is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to stay on track with therapy and in control of their disease.
-
CeQur intends to provide people with type 2 diabetes and their caregivers better tools to achieve improved control over diabetes.
-
CeQur SA Names Robert O'Holla EVP for Regulatory Affairs
CeQur SA Completes Series A Investment with 10 Million Dollar Raise in December 2009.
CeQur corporation announced on October 6, 2009 that Eric Milledge would be become Chairman of the CeQur Board of Directors.